chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received the first dose of the COVID Vaccine on 29Dec2020 and tested positive for COVID on 08Jan2021; Received the first dose of the COVID Vaccine on 29Dec2020 and tested positive for COVID on 08Jan2021; This is a spontaneous report from a non-contactable consumer.  A 45-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient received the first dose of the COVID Vaccine on 29Dec2020 and tested positive for COVID (Nasal Swab) on 08Jan2021. The outcome of the event was not recovered.   No follow-up attempts are possible. No further information is expected.
Severely swollen lymph nodes under left arm, left midclavicular and left upper throat.
Swelling of arm, vomiting, shaking, numbness and then severe pain. High grade of infection. I spent 3 days in Hospital.
red rash appeared the next day on and around the shot area. patient was advised to use benedryl cream and then reach out to her primary care if it worsens. As of submission it is still visible.
24 hours after receiving vaccines, developed a rash on the upper chest and left side of neck.
unk if adverse event pt who has mult other allergic sx including hayfever & asthma devel chronic hives;
her 31 year old boyfriend got his first vaccine dose on April 12 and shortly after he got covid; her 31 year old boyfriend got his first vaccine dose on April 12 and shortly after he got covid; This is a spontaneous report from a contactable consumer (Caregiver). A 31-year-old male patient (reporter's boyfriend) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown, NDC number, UPC number, Expiry Date: Unknown), intramuscularly on 12Apr2021 as 1st dose single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Reporter mentioned that, on an unspecified date in Apr2021, patient got Covid shortly after his first vaccine dose. After he was better his doctor said he could go to get the second dose but when he went to the pharmacy the pharmacist told him that because he was outside the 3 weeks recommended timing, he would have to repeat the series. Reporter seriousness for event was unspecified. Patient was unable to take the 2nd dose of the vaccine scheduled on 04May2021 because he tested positive with the Covid-19 virus. Reporter was advised that patient can't take the 2nd dose because it's already passed the scheduled date and that she needs to schedule an appointment for patient to start the 1st dose again. Reporter wanted to know if that is true because her doctor said that once patients Covid-19 gone, he can proceed in taking the 2nd dose. Outcome of the events were unknown.  No follow-up attempts are required; information about lot/batch number cannot be obtained.
Patient developed left-sided facial numbness approximately 25 hours post-vaccination. Numbness is on patient's left side, extends to midline of forehead, nose, chin, and includes left ear and left neck.
pt recv vax 10 days prior to rxn-presented w/t103.1 sparse macular papular rash & CBC 15,300 w/50P, 17B & CXR positive for RLL & LLL infiltrates;
03/11/2023 I started having sinus issues, sleeping, and fever. After testing positive for Covid-19 I was prescribed Paxlovid. Symptoms lasted 10 days.
Feeling foggy, like he had "smoked weed" but has not.; Dizziness; "bad" dose of the vaccine/Knows it should not be used after 6 hours, should be at room temperature for 30 minutes; "bad" dose of the vaccine/Knows it should not be used after 6 hours, should be at room temperature for 30 minutes; This is a spontaneous report from a contactable consumer (Patient) received from Pfizer Sponsored Program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient reported "bad" dose of the vaccine/knows it should not be used after 6 hours, should be at room temperature for 30 minutes on an unspecified date, feeling foggy, like he had "smoked weed" but has not and dizziness. Patient reported as what to do about his side effects, thinks they are from a bad dose of the vaccine. Reported dizziness, and feeling foggy, like he had smoked weed but has not and possibly getting a bad dose of the Pfizer BioNTech Covid-19 vaccine because he saw the person at (withheld) pull it out of a box, and he thought it was supposed to come from the freezer. Knows it shouldn't be used after 6 hours, should be at room temperature for 30 minutes, and when he asked the provider about it, he was not happy with her answer. He wants to know what to do if he got a bad vaccine. Events were considered as non-serious. Outcome of all events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt had SOB outside the 4 hour parameter.  24hrs post vaccination pt reported to PCP that he has had increased SOB more noticeable with walking, needing to stop and catch breath. Comfortable at rest. R shoulder pain since today; non radiating. Fatigue, muscle soreness, upper back cramping since yesterday. Ongoing intermittent cough, no wheeze or fever. Just used albuterol with no changes.  5/7 At PCP visit, Pt states feeling more SOB with dry cough for past couple weeks, need to use albuterol 3-4 times for past couple weeks, stopped Alvesco for 1 month after prescription run out, worsening feeling after 2nd dose of covid vaccine on 5/4/2021, no fever/chills/N/V/loss of taste or smell, no positive sick contact with covid and no recent travel out of country. No other associated symptoms. No other acute complaint today. Plan: restart CICLESONIDE 80 MCG/ACTUATION INHL HFAA - Inhale 1 Puff by mouth 2 times a day for asthma prevention and control. Pt reported reaction when presented for booster dose.  Pt cleared for booster dose by PCP.  No reaction to booster dose noted  as of 12/30/21.  Booster dose was Moderna 12/29.
Bartholin's cyst; Peeing blood / blood in her urine; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of BARTHOLIN'S CYST (Bartholin's cyst) and HAEMATURIA (Peeing blood / blood in her urine) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010a21a and 028l20a) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced BARTHOLIN'S CYST (Bartholin's cyst) and HAEMATURIA (Peeing blood / blood in her urine). In March 2021, BARTHOLIN'S CYST (Bartholin's cyst) and HAEMATURIA (Peeing blood / blood in her urine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No Treatment medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-228268, MOD-2021-228268 (Patient Link).
expired dose administered to patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   HCP states that some patients had reported flu-like symptoms after receiving the vaccination but she did not have details on that.  No Concomitant medications were reported. No Treatment medications were reported.
was given a covid vaccine instead of the regular flu vaccine with no reported adverse event; Initial information was received on 30-Sep-2021 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional (patient) via social media.    This case involves Adult female patient who received COVID-19 VACCINE instead of the regular INFLUENZA VACCINE (wrong product administered).  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect COVID-19 VACCINE not produced by Sanofi Pasteur (lot number and expired date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  It was an actual medication error due to wrong product administered. (latency: same day).  It was reported "they have and gave a 4 year old the COVID vaccine adult dosage. Supposed by mistake and a lady at a Walgreens was given a COVID vaccine instead of the regular flu vaccine".  At the time of report, no adverse event was reported.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number for this case.
After giving pt vaccine, pt had swelling at site of injection. I explained that some people do have this reaction, but had pt stay in store for a while to be sure didn't get worse. Pt said she felt fine and had no pain or other issues after waiting. Before she left, I checked arm and swelling had gone down some. Pt stated she would go home and watch to be sure and would call if any questions. She again said she was fine and wanted to go home.
This case was reported by a consumer (who was also the subject) and described the occurrence of bad aftertaste in mouth in a 44-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject's medical history included blood pressure. Concurrent medications included ATACAND and ZOCOR. The subject had previously received 1st and 2nd dose of ENGERIX B on unspecified dates with no adverse effects. On 5 May 2009 at 15:00 the subject received 3rd dose of ENGERIX B (unknown route, left arm). On 5 May 2009, within 3 hours after vaccination with ENGERIX B, the subject experienced bad aftertaste in mouth. The bad taste occurred only after foods and was not constant, but was reported to be "like a rotten taste". The subject noticed it more at the back of his tongue and throat. It had been occurring for approximately a week at the time of reporting. The subject spoke to his physician who thought it may have been a "post nasal drip". The subject reported no other symptoms. The subject may consult an Ear, Nose and Throat specialist at the recommendation of his physician. At the time of reporting the event was unresolved.
Patient came home and slept for 3 hours at 1pm after receiving the vaccion. Around 11:30PM that night he spiked a 104.7 fever, difficulty Breathing, elevated heartbeat and shaking from being so cold. Refused to eat. Took him to the hospital and they checked his ears and said he may have the start of an ear infection so gave him antibiotics. Fever has not dropped since 11/07/2015. If symptoms do not go away today, he will be going to a hospital. He won't eat, just drinking plenty of fluids. Hes throwing up from the meds and is complaining that his hair, arms, legs and belly hurts.
Sore throat developed in the evening, fever during the night (102), swollen throat, muscle aches, chills -- all symptoms ongoing & worsening.
Pfizer covid vaccine expires on 12/31/2022 but was given on 1/5/2022
I feel like I am having my pregnancies miscarriage's all over again /  My pelvic, back, legs, spine, neck, head and all my bones are killing me.; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient (110 pounds) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 03Jun2021 18:00 (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for covid-19 immunisation in Pharmacy or Drug Store. Medical history included heart condition and known allergies: Sulfa. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No medications the patient received within 2 weeks of vaccination. The patient previously took bnt162b2 for covid-19 immunisation at Left arm on 13May2021 18:00. The patient reported that she felt like she was having her pregnancies miscarriage was all over again / her pelvic, back, legs, spine, neck, head and all her bones are killing her on 04Jun2021 12:00 with outcome of unknown. It was unknown if any treatment was received. The patient was just wondering if the same dose or different doses of this vaccine should be the same. Her husband was 200 pounds and she was 110 pounds. She was a smaller person. Should she had a smaller does? She felt like she had been overdosed with Pfizer. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Local reaction - pain, erythema started 5/16 - MOTRIN and BENADRYL given.
pt recvd vax;adm to hosp for acute myopathy;neurologist felt mult sclerosis or post vax spinal synd;discharged 4nov;;f/u recent spinal cord synd w/ lt lower extremity weakness;now ability to walk w/ a cane;
Full blown case of chicken pox including fever for 3+ days, runny nose, and pox everywhere including every extremity, face, lips, inside mouth, and trunk. Took "normal" course of virus so far (we are on day 4 of pox development).  Every day # of pox and distribution has increased. Old pox blister and then scab while new pox pop out.
Weak, sleep, Headached, fever flu like symtpoms.  Went to an urgent close to home and they stated she was having an allergic reaction, she was given a shot to conteract the symptoms according to patient.
BECAME ILL AFTER VACCINE -WEAK- DURING THAT NIGHT HAD SEIZURE- NO FEVER, WHITE COUNT NORMAL,WENT ON TO HAVE SEIZURES, IN INTENSIVE CARE UNIT, SYMPTOMS WORSENED AND CVA SYMPTOMS AND TRANSFERRED TO HOSPITAL.
This spontaneous report as received from an approximately 53 year old female patient regarding herself. The patient's pertinent medical history included allergies (unspecified) (hypersensitivity) and iodine dye allergy. On an unknown date approximately in July 2010 the patient was vaccinated with first dose of RECOMBIVAX HB dose 1, (lot number and expiry date unknown) intramuscularly (dosing regimen and frequency unknown) for prevention of infection of hepatitis B virus. It was reported that the patient was recommended to get the RECOMBIVAX HB due to working in the fire department. Concomitant therapies included SINGULAIR and ALLEGRA. On an unknown date in December 2010 the patient received the second dose, and on an unknown date in February 2011 the patient received the third dose of RECOMBIVAX HB (lot number and expiry date unknown) intramuscularly (dosing regimen and frequency unknown) for prevention of infection of hepatitis B virus). On an unknown date approximately in March 2011 (also reported as about 6-8 weeks after receiving the third shot) the patient experienced tingling numbing feeling in her left eye, the tingling numbing feeling migrated to the nose, cheek, tongue, teeth, and lips all on the left side of the face. It was reported that the tingling numbing feeling stops about half an inch below lip. The patient stated that the feeling was 24 hours a day and it felt like procaine (Novocaine) when it was wearing off. The patient had visited a neurologist (unspecified), and an ear, nose and throat specialist (unspecified) and a neuropathy specialist (unspecified). The patient had also had an acupuncture seen a chiropractor (unspecified) for an MES. The patient visited a dentist (unspecified) who had her wearing a night guard. The patient had undergone a Magnetic resonance imaging (MRI), computerized axial tomography (CAT) Scan and blood tests (unspecified) but the results were not reported. It was reported that the patient did not receive any treatments for the events. The action taken with the therapy with RECOMBIVAX HB was unknown. The outcome of the events was not recovered. It was also reported that the patient was told that she may have to just live with it. The relatedness of the events to the therapy with RECOMBIVAX HB was unknown. There was no product quality issue reported. Additional information has been requested.
Dizziness, Headache, Sedation, Myalgia, Arthralgia, Pain at injection site Narrative:
CHILLS, BODY MALAISE, CONFIRMED TODAY  TEMPARATURE 100.1.4
Shot given on 1/29/03. By the evening, she started having rhythmic uncontrollable jerking of the left arm. 5-8 jerks per episode. No loss of consciousness. No other symptoms other than mild fever on 1/30/03.
COVID vaccine breakthrough case. Moderna 3/8/21 012A21A, 4/6/21 017B21A and boosted 12/8/21 067F (lot number stated).
extremely tired; Discomfort to Injection Site; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 79 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 27Feb2021 14:00 (Lot number: EN6202) at the age of 79 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Arthritis", start date: 2010 (ongoing), notes: None; "High BP", start date: 2001 (ongoing), notes: Controlled by medication. Family history included: "Hx of cancer" (unspecified if ongoing), notes: Hx of cancer + high BP. Concomitant medication(s) included: LISINOPRIL taken for hypertension, start date: 2001 (ongoing); LISINOPRIL/HCTZ taken for hypertension, start date: 2001 (ongoing). Vaccination history included: Bnt162b2 (Date: 06Feb2021, Time: 13:00, Anatomical Location: Right Fore Arm, Lot. No. EL324), administration date: 06Feb2021, for COVID-19 immunisation, reaction(s): "discomfort to injection site". The following information was reported: FATIGUE (non-serious) with onset 27Feb2021 18:00, outcome "unknown", described as "extremely tired"; VACCINATION SITE DISCOMFORT (non-serious) with onset 27Feb2021 18:00, outcome "unknown", described as "Discomfort to Injection Site".  Additional information: The patient provided information to regarding the reported adverse event(s) with the use of the product: Yes, Self. The reporter consider the Pfizer product had a casual effect to the adverse event.  No follow-up attempts are possible. No further information is expected.
L knee swelling and pain. 11/13/2009 developed rash.  Diagnosed with Henoch Schonlein Purpora.  No renal involvement at time of diagnosis.
First my period was late by 5 days, cause my migraine with auras to pick up frequently, and now a week after getting off my period I?m now on my period again
Pt felt dizzy lightheaded and diaphoretic 15 min post vaccination Reports similar symptoms with other vaccinations/shots placed on the stretcher, 1 can of orange juice provided patient felt better after resting and orange juice
patient received Havrix on 10AUG2023 that expired on 17JUN2023; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 25-year-old female patient who received HAV (Havrix 1440 adult) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis.   On 10-AUG-2023, the patient received Havrix 1440 adult. On 10-AUG-2023, an unknown time after receiving Havrix 1440 adult, the patient experienced expired vaccine used (Verbatim: patient received Havrix on 10AUG2023 that expired on 17JUN2023). The outcome of the expired vaccine used was unknown.   Additional Information: Receipt Date: 10-AUG-2023 The health care professional (HCP) reported that the patient received a dose of Havrix on 10th August 2023 which was expired on 17th June 2023, which led to expired vaccine used. The reporter consented to follow up.
After 3-5  hours of vaccine, my son started to show signs like it was hard for him to breathe, holding his breath along with body stiffening while me and him was moved to post partum floor..It happened 2-3 times until I got scared because my son lips was turning blue. I then advise the nurse,  nurse toom him to nursery and from the moment , like 5 min he was rushed and admitted to nicu for seizures.  He was in the nicu for 21 days and he also suffered a blood clot call central venus sinus thrombosis , that the dr's stated the blood clot most likely did not cause the seizures.  Every single genetic test was done and all was negative for any genetic mutation . My son now has to take 3 seizures meds every day + he is on a blood thinner shot as well.
24 hours after immunization, pt experienced a raised red bump that itched and persisted for at least 12 hours.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated with lot # (670978/0750AA) ZOSTAVAX on 15-SEP-2012. No other co-suspects were reported. No concomitant medications were reported. On 15-SEP-2012 the patient received expired ZOSTAVAX (expiry date 18-AUG-2012). No known adverse effects were reported. This case is linked to case 1209USA011717 by same reporter link. Additional information has been requested.
Patient reports redness and irritation at the injection site, woke with a headache today, feeling fatigued, nauseated and describes left arm pain.
Mild soreness at site of injection; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old patient received bnt162b2 (BNT162B2), intramuscular, administration date 30Mar2021 13:20 (Lot number: EP6955) as dose 2, single and intramuscular, administration date 09Mar2021 13:20 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Heartburn", start date: 01Nov2020 (ongoing), notes: Pertinent details: Correctly Taking Famotidine 2x daily; "Acid Reflux", start date: 01Nov2020 (ongoing), notes: Acid Reflux, Pertinent details: Correctly Taking Famotidine 2x daily. Concomitant medication(s) included: FAMOTIDINE taken for gastrooesophageal reflux disease, start date: Jul2021 (ongoing). The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "Mild soreness at site of injection".  Additional information: Patient did not experience any side effects from first two shots except for mild soreness at site of injection. The vaccination facility type was workplace clinic. Prior vaccinations was none.   Follow-up attempts are completed. No further information is expected.